ataraxia 15 limited
ataraxia 15 limited Company Information
Company Number
14080388
Next Accounts
Sep 2025
Shareholders
peter cullum
ann cullum
View AllGroup Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
venture house st. leonards road, allington, maidstone, ME16 0LS
Website
-ataraxia 15 limited Estimated Valuation
Pomanda estimates the enterprise value of ATARAXIA 15 LIMITED at £648.8k based on a Turnover of £574.9k and 1.13x industry multiple (adjusted for size and gross margin).
ataraxia 15 limited Estimated Valuation
Pomanda estimates the enterprise value of ATARAXIA 15 LIMITED at £0 based on an EBITDA of £-38.3k and a 4.69x industry multiple (adjusted for size and gross margin).
ataraxia 15 limited Estimated Valuation
Pomanda estimates the enterprise value of ATARAXIA 15 LIMITED at £0 based on Net Assets of £-36.9k and 1.34x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ataraxia 15 Limited Overview
Ataraxia 15 Limited is a live company located in maidstone, ME16 0LS with a Companies House number of 14080388. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in May 2022, it's largest shareholder is peter cullum with a 53.5% stake. Ataraxia 15 Limited is a startup, small sized company, Pomanda has estimated its turnover at £574.9k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ataraxia 15 Limited Health Check
Pomanda's financial health check has awarded Ataraxia 15 Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 5 areas for improvement. Company Health Check FAQs
0 Strong
3 Regular
5 Weak
Size
annual sales of £574.9k, make it smaller than the average company (£18.9m)
- Ataraxia 15 Limited
£18.9m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Ataraxia 15 Limited
- - Industry AVG
Production
with a gross margin of 36.3%, this company has a comparable cost of product (36.3%)
- Ataraxia 15 Limited
36.3% - Industry AVG
Profitability
an operating margin of -6.7% make it less profitable than the average company (4.5%)
- Ataraxia 15 Limited
4.5% - Industry AVG
Employees
with 3 employees, this is below the industry average (104)
3 - Ataraxia 15 Limited
104 - Industry AVG
Pay Structure
on an average salary of £44.7k, the company has an equivalent pay structure (£44.7k)
- Ataraxia 15 Limited
£44.7k - Industry AVG
Efficiency
resulting in sales per employee of £191.6k, this is equally as efficient (£191.6k)
- Ataraxia 15 Limited
£191.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Ataraxia 15 Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Ataraxia 15 Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Ataraxia 15 Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (14 weeks)
0 weeks - Ataraxia 15 Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 102.4%, this is a higher level of debt than the average (69.6%)
102.4% - Ataraxia 15 Limited
69.6% - Industry AVG
ATARAXIA 15 LIMITED financials
Ataraxia 15 Limited's latest turnover from December 2023 is estimated at £574.9 thousand and the company has net assets of -£36.9 thousand. According to their latest financial statements, Ataraxia 15 Limited has 3 employees and maintains cash reserves of £19.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | |
|---|---|---|
| Turnover | ||
| Other Income Or Grants | ||
| Cost Of Sales | ||
| Gross Profit | ||
| Admin Expenses | ||
| Operating Profit | ||
| Interest Payable | ||
| Interest Receivable | ||
| Pre-Tax Profit | ||
| Tax | ||
| Profit After Tax | ||
| Dividends Paid | ||
| Retained Profit | ||
| Employee Costs | ||
| Number Of Employees | 3 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | |
|---|---|---|
| Tangible Assets | 962,970 | |
| Intangible Assets | ||
| Investments & Other | ||
| Debtors (Due After 1 year) | ||
| Total Fixed Assets | 962,970 | |
| Stock & work in progress | ||
| Trade Debtors | ||
| Group Debtors | ||
| Misc Debtors | 561,880 | |
| Cash | 19,509 | 1 |
| misc current assets | ||
| total current assets | 581,389 | 1 |
| total assets | 1,544,359 | 1 |
| Bank overdraft | ||
| Bank loan | ||
| Trade Creditors | ||
| Group/Directors Accounts | ||
| other short term finances | ||
| hp & lease commitments | ||
| other current liabilities | 1,486,752 | |
| total current liabilities | 1,486,752 | |
| loans | ||
| hp & lease commitments | ||
| Accruals and Deferred Income | ||
| other liabilities | 94,500 | |
| provisions | ||
| total long term liabilities | 94,500 | |
| total liabilities | 1,581,252 | |
| net assets | -36,893 | 1 |
| total shareholders funds | -36,893 | 1 |
| Dec 2023 | Dec 2022 | |
|---|---|---|
| Operating Activities | ||
| Operating Profit | ||
| Depreciation | ||
| Amortisation | ||
| Tax | ||
| Stock | ||
| Debtors | 561,880 | |
| Creditors | ||
| Accruals and Deferred Income | 1,486,752 | |
| Deferred Taxes & Provisions | ||
| Cash flow from operations | ||
| Investing Activities | ||
| capital expenditure | ||
| Change in Investments | ||
| cash flow from investments | ||
| Financing Activities | ||
| Bank loans | ||
| Group/Directors Accounts | ||
| Other Short Term Loans | ||
| Long term loans | ||
| Hire Purchase and Lease Commitments | ||
| other long term liabilities | 94,500 | |
| share issue | ||
| interest | ||
| cash flow from financing | ||
| cash and cash equivalents | ||
| cash | 19,508 | 1 |
| overdraft | ||
| change in cash | 19,508 | 1 |
ataraxia 15 limited Credit Report and Business Information
Ataraxia 15 Limited Competitor Analysis
Perform a competitor analysis for ataraxia 15 limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other small companies, companies in ME16 area or any other competitors across 12 key performance metrics.
ataraxia 15 limited Ownership
ATARAXIA 15 LIMITED group structure
Ataraxia 15 Limited has no subsidiary companies.
Ultimate parent company
ATARAXIA 15 LIMITED
14080388
ataraxia 15 limited directors
Ataraxia 15 Limited currently has 3 directors. The longest serving directors include Mr David Clapp (Jun 2023) and Mr Peter Cullum (Jun 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr David Clapp | United Kingdom | 49 years | Jun 2023 | - | Director |
| Mr Peter Cullum | United Kingdom | 74 years | Jun 2023 | - | Director |
| Mr Christian Parker | 43 years | Nov 2023 | - | Director |
P&L
December 2023turnover
574.9k
0%
operating profit
-38.3k
0%
gross margin
36.4%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-36.9k
-36894%
total assets
1.5m
+1544358%
cash
19.5k
+19508%
net assets
Total assets minus all liabilities
Similar Companies
ataraxia 15 limited company details
company number
14080388
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
May 2022
age
3
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
LB GROUP
auditor
-
address
venture house st. leonards road, allington, maidstone, ME16 0LS
Bank
-
Legal Advisor
-
ataraxia 15 limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ataraxia 15 limited.
ataraxia 15 limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ATARAXIA 15 LIMITED. This can take several minutes, an email will notify you when this has completed.
ataraxia 15 limited Companies House Filings - See Documents
| date | description | view/download |
|---|
